C07C 229/60
With amino and carboxyl groups bound in meta- or para- positions
Official title: with amino and carboxyl groups bound in meta- or para- positions
C07C229/60 (With amino and carboxyl groups bound in meta- or para- positions) appears on 263 US grants and 254 published applications in this corpus.
Search patents in C07C- Granted patents
- 263
- Published applications
- 254
- Assignees
- 193
- Inventors
- 746
- Latest grant
- 10 Feb 2026
Filings by year
| Year | Granted patents | Published applications |
|---|---|---|
| 1976 | 1 | 0 |
| 1977 | 0 | 0 |
| 1978 | 1 | 0 |
| 1979 | 0 | 0 |
| 1980 | 0 | 0 |
| 1981 | 0 | 0 |
| 1982 | 1 | 0 |
| 1983 | 1 | 0 |
| 1984 | 0 | 0 |
| 1985 | 1 | 0 |
| 1986 | 0 | 0 |
| 1987 | 0 | 0 |
| 1988 | 1 | 0 |
| 1989 | 1 | 0 |
| 1990 | 0 | 0 |
| 1991 | 1 | 0 |
| 1992 | 8 | 0 |
| 1993 | 9 | 0 |
| 1994 | 2 | 0 |
| 1995 | 7 | 0 |
| 1996 | 6 | 0 |
| 1997 | 10 | 0 |
| 1998 | 18 | 0 |
| 1999 | 5 | 0 |
| 2000 | 8 | 0 |
| 2001 | 1 | 0 |
| 2002 | 14 | 11 |
| 2003 | 4 | 17 |
| 2004 | 15 | 11 |
| 2005 | 6 | 12 |
| 2006 | 4 | 6 |
| 2007 | 8 | 8 |
| 2008 | 4 | 15 |
| 2009 | 4 | 13 |
| 2010 | 9 | 10 |
| 2011 | 9 | 11 |
| 2012 | 6 | 5 |
| 2013 | 4 | 7 |
| 2014 | 7 | 16 |
| 2015 | 11 | 9 |
| 2016 | 12 | 10 |
| 2017 | 6 | 8 |
| 2018 | 5 | 13 |
| 2019 | 13 | 17 |
| 2020 | 6 | 7 |
| 2021 | 9 | 7 |
| 2022 | 9 | 10 |
| 2023 | 3 | 8 |
| 2024 | 5 | 12 |
| 2025 | 6 | 3 |
| 2026 | 2 | 8 |
By publication year. Applications have been published since 2001. 2026 runs to 8 Oct.
Recent patents
- Mixture of isomers of aminaphtone, analytical method for identifying them and pharmaceutical composition comprising said isomers10 Feb 2026US 12,546,756 B2Laboratori Baldacci SpA
- Compositions comprising a retinoid X receptor (RXR) agonist, a retinoic acid receptor (RAR) agonist, or a dual RXR/RAR agonist3 Feb 2026US 12,540,121 B2Arizona Board of Regents on behalf of Arizona State University
- Carbonic acid adducts2 Dec 2025US 12,486,217 B2Inflamed Pharma GmbH
- Long-acting low-addiction HNK derivative and preparation method therefor11 Nov 2025US 12,466,785 B2Shenzhen Ruijian Biotechnology Co., Ltd
- Cocrystals of posaconazole, methods of making and using same7 Oct 2025US 12,435,069 B2The Regents of the University of Michigan
- Therapeutic compounds1 Oct 2026US 2026/0297016 A1Regents of the University of Minnesota
- Substituted 3-fluorobenzenepropanoate compound and preparation method therefor, pharmaceutical composition thereof, and use thereof14 May 2026US 2026/0132115 A1Tianjin Gudui Bio-Pharm Co., Ltd.
- Compositions Comprising a Retinoid X Receptor (RXR) Agonist, a Retinoic Acid Receptor (RAR) Agonist, or a Dual RXR/RAR Agonist16 Apr 2026US 2026/0103445 A1Arizona Board of Regents on behalf of Arizona State University
- Resist composition, method for forming resist pattern, compound, and polymer compound26 Mar 2026US 2026/0086458 A1Tokyo Ohka Kogyo.Co., Ltd.
- Improved process for preparing p-nitrobenzoic acid-2-ethylhexyl ester19 Mar 2026US 2026/0078083 A1BASF SE
Most cited
By later US patents
- Methods and compositions for inhibiting cell proliferative disorders109US 5,789,427 ASugen, Inc. · 1998
- FLK-1 is a receptor for vascular endothelial growth factor90US 5,851,999 AMax-Planck-Gesellschaft Zur FöRderung Der Wissenschaften E. V. · 1998
- Methods and compositions for inhibiting cell proliferative disorders85US 5,773,476 ASugen, Inc. · 1998
- Quinazoline compounds and compositions thereof for the treatment of disease84US 5,792,771 ASugen, Inc. · 1998
- Compounds for the treatment of disorders related to vasculogenesis and/or angiogenesis64US 5,712,395 ASugen, Inc. · 1998